![Molecules | Free Full-Text | Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products | HTML Molecules | Free Full-Text | Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products | HTML](https://www.mdpi.com/molecules/molecules-26-04100/article_deploy/html/images/molecules-26-04100-g001.png)
Molecules | Free Full-Text | Targeting the PI3K/AKT/mTOR Signaling Pathway in Lung Cancer: An Update Regarding Potential Drugs and Natural Products | HTML
![Cancers | Free Full-Text | The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review | HTML Cancers | Free Full-Text | The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review | HTML](https://www.mdpi.com/cancers/cancers-13-03949/article_deploy/html/images/cancers-13-03949-g001.png)
Cancers | Free Full-Text | The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review | HTML
![The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? | Future Medicinal Chemistry The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? | Future Medicinal Chemistry](https://www.future-science.com/cms/10.4155/fmc.15.55/asset/images/medium/figure1.gif)
The PI3K/Akt/PTEN/mTOR pathway: a fruitful target for inducing cell death in rheumatoid arthritis? | Future Medicinal Chemistry
![Frontiers | Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer | Pharmacology Frontiers | Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer | Pharmacology](https://www.frontiersin.org/files/Articles/628690/fphar-12-628690-HTML/image_m/fphar-12-628690-g001.jpg)
Frontiers | Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer | Pharmacology
![Frontiers | The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions | Immunology Frontiers | The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions | Immunology](https://www.frontiersin.org/files/Articles/28432/fimmu-03-00224-HTML/image_m/fimmu-03-00224-g001.jpg)
Frontiers | The phosphoinositide 3-kinase signaling pathway in normal and malignant B cells: activation mechanisms, regulation and impact on cellular functions | Immunology
![Frontiers | Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors? | Immunology Frontiers | Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors? | Immunology](https://www.frontiersin.org/files/Articles/595818/fimmu-11-595818-HTML-r1/image_m/fimmu-11-595818-g001.jpg)
Frontiers | Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors? | Immunology
![Targeting PI3K/Akt signal transduction for cancer therapy | Signal Transduction and Targeted Therapy Targeting PI3K/Akt signal transduction for cancer therapy | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00828-5/MediaObjects/41392_2021_828_Fig1_HTML.png)
Targeting PI3K/Akt signal transduction for cancer therapy | Signal Transduction and Targeted Therapy
![RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours | Cell & Bioscience | Full Text RETRACTED ARTICLE: Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours | Cell & Bioscience | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13578-020-00416-0/MediaObjects/13578_2020_416_Fig1_HTML.png)